The company has installed a veteran mining geologist to lead exploration, while its planned purchase of six Atlantic Canada gold properties still hinges on approval from the seller’s shareholders.

July 13, 2026

Nu-Med Plus, Inc., a Utah company quoted on the OTCQB Venture Market, has completed its acquisition of Avid Gold Ltd, pushing a small medical-device issuer into Canadian gold exploration. With the deal closed, Avid Gold and its wholly owned operating subsidiary, Maritimes Gold Corp., now sit under Nu-Med, which said it will run the new gold business alongside its existing medical-device operations.

Alongside the closing, Nu-Med and its subsidiaries entered into a Mineral Property Purchase Agreement with MegumaGold Corp. and two of its subsidiaries to acquire six gold properties in Nova Scotia, New Brunswick, and Newfoundland and Labrador. That purchase has not yet closed; it remains subject to conditions that include approval by MegumaGold’s shareholders, and the company noted it may not close on a timely basis, or at all. This completes the combination outlined in the parties’ late-June agreements.

An Atlantic Canada gold footprint

The properties cover more than 30,900 acres of mineral claims in Atlantic Canada, and four of the six sit within the Meguma Terrane, which the company described as one of Canada’s most significant gold-producing regions. Maritimes Gold’s stated focus is identifying high-grade exploration targets and advancing them through exploration, development, and production.

A reshaped leadership team

The transaction also reorders Nu-Med’s leadership:

• William Hayde, previously chief executive, becomes chairman of the board.
• Keith Merrell continues as chief financial officer and a director.
• Fred Tejada joined the board on closing and takes on the roles of senior vice president and chief geologist.

The company said Tejada brings more than 40 years of international mining experience spanning gold, copper, nickel, cobalt, and coal, and has been involved in advancing the properties; he will lead its gold exploration effort. Hayde said the company is diversifying its activities through the Avid Gold acquisition and intends to work toward maximizing the value of the gold portfolio for shareholders once the property purchase closes.

The announcement formalizes Nu-Med’s dual identity as both a medical-device company and an early-stage gold explorer. Fuller execution of the strategy, however, still depends on the pending property acquisition and, as the company acknowledged, on its ability to secure additional financing.